Weight Loss News and Research

Latest Weight Loss News and Research

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI(TM) (golimumab) resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis (RA) and active psoriatic arthritis (PsA).

20 Oct 2009

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

Elan Corporation, plc and Biogen Idec today announced multiple presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place October 23-28 in San Diego.

20 Oct 2009

Amylin Pharmaceuticals to present new data from its obesity program at Obesity 2009

Amylin Pharmaceuticals, Inc. today announced that new data from its obesity program will be presented at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society, to be held in Washington, D.C. October 24-28. Phase 2 data from the pramlintide/metreleptin combination treatment clinical program will be the subject of a late-breaking oral presentation.

20 Oct 2009

Website answers questions about 'end of life'

Questions about end of life are as old as humanity, yet they can be new and overwhelming when someone we care about is dying.

19 Oct 2009

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis (RA) receiving SIMPONI(TM) (golimumab) every four weeks achieved sustained improvements in signs and symptoms and physical function response through one year. These new data were presented today at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting.

19 Oct 2009

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough announced that data on boceprevir, an investigational hepatitis C virus (HCV) protease inhibitor, will be reported in an oral presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston, Oct. 30-Nov. 3.

19 Oct 2009

"A Stroke of Health" for the weight loss benefits of healthy eating

Friday the 13th in June 2008 started out as a normal day for Bob and Judi Swartz, but the day would end as anything but ordinary. Bob would suffer a serious stroke and Judi would take the first steps in a year-long journey of recovery and discovery.

15 Oct 2009

National Institutes of Health grants $12 million to WCDRC for obesity research

The Miriam Hospital's Weight Control and Diabetes Research Center (WCDRC) recently received six research grants from the National Institutes of Health - totaling more than $12 million in funding - that will support the work of researchers focused on the prevention and treatment of obesity.

15 Oct 2009

Researchers to study gastric banding procedure on overweight, type 2 diabetic patients

In the first trial of its kind in the world, researchers at Monash University's Centre for Obesity Research and Education (CORE) will examine the benefits of a gastric banding procedure on overweight people with Type 2 diabetes.

15 Oct 2009

New evidence indicates humans naturally regulate their salt intake

As the 2010 Dietary Guidelines for Americans are currently under development and regulations surrounding sodium consumption are being considered, an analysis of evidence released online today in the Clinical Journal of the American Society of Nephrology (CJASN) questions the scientific logic and feasibility of the decades-long effort to limit salt intake in humans.

15 Oct 2009

Diet and exercise program unlikely to eliminate OSA in overweight patients

A study in the Oct. 15 issue of the Journal of Clinical Sleep Medicine found that while a strict diet and exercise program may benefit obese patients with mild to moderate obstructive sleep apnea (OSA), it is unlikely to eliminate the condition.

15 Oct 2009

ValenTx to present its first clinical study for the treatment of morbid obesity

ValenTx, Inc. announces the presentation of the first clinical study of their endoluminal approach for the treatment of morbid obesity at the 2009 American College of Surgeons Clinical Congress.

15 Oct 2009

American Recovery and Reinvestment Act funds to support research in numerous health areas

As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.

14 Oct 2009

Kaiser Permanente receives $54 million grant from NIH to conduct health research

14 Oct 2009

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic findings in the fields of obesity and osteoporosis at medical meetings later this month.

13 Oct 2009

Merck Frosst Canada's JANUMET receives Notice of Compliance in Canada

Merck Frosst Canada Ltd. announced today that its new diabetes treatment, JANUMET(TM) (sitagliptin/metformin HCI, MSD), has received Notice of Compliance (NoC) in Canada.

13 Oct 2009

A new site and blog for dieters to share information launched by DietReality.com

In response to an increasing need to provide up-to-date information on safe and effective weight loss products, DietReality.com has launched a new site and blog designed to empower dieters to share information.

12 Oct 2009

Arena Pharmaceuticals to present Phase 3 BLOSSOM trial results at Obesity 2009

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that lorcaserin will be featured in multiple presentations at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society in Washington, DC.

12 Oct 2009

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

12 Oct 2009

Eat Right America Nutrition Prescription Solution on ShopNBC

ShopNBC, the premium lifestyle brand in electronic retailing, today announced the launch of the "Eat Right America" show series on its multi-channel platform this Saturday, October 10 at 2 am, 8 am, and 3 pm ET.

12 Oct 2009

Weight Loss News and Research

Latest Weight Loss News and Research

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

Amylin Pharmaceuticals to present new data from its obesity program at Obesity 2009

Website answers questions about 'end of life'

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

"A Stroke of Health" for the weight loss benefits of healthy eating

National Institutes of Health grants $12 million to WCDRC for obesity research

Researchers to study gastric banding procedure on overweight, type 2 diabetic patients

New evidence indicates humans naturally regulate their salt intake

Diet and exercise program unlikely to eliminate OSA in overweight patients

ValenTx to present its first clinical study for the treatment of morbid obesity

American Recovery and Reinvestment Act funds to support research in numerous health areas

Kaiser Permanente receives $54 million grant from NIH to conduct health research

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

Merck Frosst Canada's JANUMET receives Notice of Compliance in Canada

A new site and blog for dieters to share information launched by DietReality.com

Arena Pharmaceuticals to present Phase 3 BLOSSOM trial results at Obesity 2009

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Eat Right America Nutrition Prescription Solution on ShopNBC

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Weight Loss News and Research

Latest Weight Loss News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in